West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
254.80
+2.06 (0.82%)
At close: Apr 2, 2026, 4:00 PM EDT
253.88
-0.92 (-0.36%)
After-hours: Apr 2, 2026, 7:00 PM EDT
WST Revenue
In the year 2025, West Pharmaceutical Services had annual revenue of $3.07B with 6.25% growth. West Pharmaceutical Services had revenue of $805.00M in the quarter ending December 31, 2025, with 7.51% growth.
Revenue (ttm)
$3.07B
Revenue Growth
+6.25%
P/S Ratio
5.97
Revenue / Employee
$284,639
Employees
10,800
Market Cap
18.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.07B | 180.90M | 6.25% |
| Dec 31, 2024 | 2.89B | -56.60M | -1.92% |
| Dec 31, 2023 | 2.95B | 62.90M | 2.18% |
| Dec 31, 2022 | 2.89B | 55.30M | 1.95% |
| Dec 31, 2021 | 2.83B | 684.70M | 31.89% |
| Dec 31, 2020 | 2.15B | 307.00M | 16.69% |
| Dec 31, 2019 | 1.84B | 122.50M | 7.13% |
| Dec 31, 2018 | 1.72B | 118.30M | 7.40% |
| Dec 31, 2017 | 1.60B | 90.00M | 5.96% |
| Dec 31, 2016 | 1.51B | 109.30M | 7.81% |
| Dec 31, 2015 | 1.40B | -21.60M | -1.52% |
| Dec 31, 2014 | 1.42B | 53.00M | 3.87% |
| Dec 31, 2013 | 1.37B | 102.00M | 8.05% |
| Dec 31, 2012 | 1.27B | 74.10M | 6.21% |
| Dec 31, 2011 | 1.19B | 87.60M | 7.93% |
| Dec 31, 2010 | 1.10B | 49.00M | 4.64% |
| Dec 31, 2009 | 1.06B | 4.60M | 0.44% |
| Dec 31, 2008 | 1.05B | 31.00M | 3.04% |
| Dec 31, 2007 | 1.02B | 106.80M | 11.69% |
| Dec 31, 2006 | 913.30M | 213.60M | 30.53% |
| Dec 31, 2005 | 699.70M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Becton, Dickinson and Company | 21.92B |
| Baxter International | 11.24B |
| Alcon | 10.40B |
| Solventum | 8.33B |
| ResMed | 5.40B |
| Bausch + Lomb | 5.10B |
| The Cooper Companies | 4.15B |
| Hologic | 4.13B |
WST News
- 3 days ago - The Old Market Playbook Is Breaking - This Is The Strategy I'm Betting On - Seeking Alpha
- 4 days ago - West Expands Dublin Facility to Support High-Volume Injectable Therapies, Including Diabetes and Obesity - PRNewsWire
- 14 days ago - Best Dividend Aristocrats As Of March 20, 2026 - Seeking Alpha
- 17 days ago - West Pharmaceutical Services, Inc. (WST) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript - Seeking Alpha
- 25 days ago - West Pharmaceutical Services, Inc. (WST) Presents at Barclays 28th Annual Global Healthcare Conference Transcript - Seeking Alpha
- 26 days ago - West Pharma CEO Eric Green to retire after 11 years at the helm - Reuters
- 26 days ago - Eric M. Green Informs Board of Plans to Retire as President, CEO and Chair of the Board of West Pharmaceutical Services, Inc. - PRNewsWire
- 5 weeks ago - Best Dividend Aristocrats For March 2026 - Seeking Alpha